Canna~Fangled Abstracts

Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease.

By May 1, 2018No Comments
Ther Adv Cardiovasc Dis. 2018 May 1:1753944718773690. doi: 10.1177/1753944718773690.
[Epub ahead of print]

Abstract

PM 2 site 207Cardiovascular disease is currently not adequately managed and has become one of the main causes of morbidity and mortality worldwide. Current therapies are inadequate in terms of preventing its progression. There are several limitations, such as poor oral bioavailability, side effects, low adherence to treatment, and high dosage frequency of formulations due to the short half-life of the active ingredients used, among others. This review aims to highlight the most relevant aspects of the relationship between the cardiovascular system and the endocannabinoid system, with special attention to the possible translational effect of the use of anandamide in cardiovascular health. The deep and detailed knowledge of this interaction, not always beneficial, and that for years has gone unnoticed, is essential for the development of new therapies. We discuss the most recent and representative results obtained in the field of basic research, referring to the aforementioned subject, emphasizing fundamentally the main role of nitric oxide, renal physiology and its deregulation in pathological processes.

KEYWORDS:

CB1 receptors; anandamide; cardiovascular disease; endocannabinoid system; nitric oxide

PMID: 29764302
DOI: 10.1177/1753944718773690
twin memes II